Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 6,400 | 3,655 | 4,674 | 3,645 | 53,129 |
| Operating Income | -6,400 | -3,655 | -4,674 | -3,645 | -53,129 |
| Interest Expense | 38 | 59 | 306 | 255 | 104 |
| Other Income | 78 | 622 | 142 | -172 | -835 |
| Pre-tax Income | -6,360 | -3,091 | -4,838 | -4,072 | -54,067 |
| Net Income Continuous | -6,360 | -3,091 | -4,838 | -4,072 | -54,067 |
| Net Income | $-6,360 | $-3,091 | $-4,838 | $-4,072 | $-54,067 |
| EPS Basic Total Ops | -7.00 | -7.50 | -9.75 | 1,646.25 | -312.50 |
| EPS Basic Continuous Ops | -7.09 | -5.78 | -9.81 | 1,646.34 | -312.46 |
| EPS Diluted Total Ops | -7.00 | -7.50 | -9.75 | 1,646.25 | -312.50 |
| EPS Diluted Continuous Ops | -7.09 | -5.78 | -9.81 | 1,646.34 | -312.46 |
| EPS Diluted Before Non-Recurring Items | -7.00 | -7.50 | -9.75 | N/A | -312.50 |
| EBITDA(a) | $-6,400 | $-3,655 | $-4,673 | $-3,645 | $-53,129 |